Evidence map›Paper›PMID 40016677›Full record

ArticleBMC cancer2025

The prealbumin-CD19

Hongming Pan, Hao Sun, Yanjiao Zuo, Ruihu Zhao, Yingwei Xue, Hongjiang Song

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hongming Pan *Department of Gastrointestinal Surgery, Harbin Medical University Cancer Hospital, Harbin Medical University, 150 Haping Road, Nangang District, Harbin, Heilongjiang, 150081, China.
Hao Sun *Department of Breast Surgery, Sixth Affiliated Hospital of Harbin Medical University, Harbin, 150023, China.
Yanjiao ZuoDepartment of Gastrointestinal Surgery, Harbin Medical University Cancer Hospital, Harbin Medical University, 150 Haping Road, Nangang District, Harbin, Heilongjiang, 150081, China.
Ruihu ZhaoDepartment of Gastrointestinal Surgery, Harbin Medical University Cancer Hospital, Harbin Medical University, 150 Haping Road, Nangang District, Harbin, Heilongjiang, 150081, China.
Yingwei XueDepartment of Gastrointestinal Surgery, Harbin Medical University Cancer Hospital, Harbin Medical University, 150 Haping Road, Nangang District, Harbin, Heilongjiang, 150081, China.
Hongjiang SongDepartment of Gastrointestinal Surgery, Harbin Medical University Cancer Hospital, Harbin Medical University, 150 Haping Road, Nangang District, Harbin, Heilongjiang, 150081, China. 600911@hrbmu.edu.cn.

Funding

Wu Jieping Medical Foundation 320.6750.2022-07-13
6 · The paper itself

Abstract

objectiveThis study aimed to establish a prealbumin (PALB)-CD19

methodsA total of 389 patients who were diagnosed with GC and who underwent surgical procedures at our institution between January 2016 and December 2020 were included in this study. Among them, 97 patients underwent subtotal gastrectomy, 271 underwent total gastrectomy, and 21 underwent palliative resection. The PALB-CD19

resultsThis study included 389 patients, 276 males and 113 females, with a mean age of 59.10 ± 10.19 years. Cox analysis identified PALB and CD19

conclusionsThe PALB-CD19

Indexed as

Antigens, CD19PrealbuminStomach NeoplasmsAdultAgedBiomarkers, TumorFemaleGastrectomyHumansMaleMiddle AgedNomogramsPrognosisRetrospective StudiesROC CurveAntigens, CD19Biomarkers, TumorCD19 molecule, humanPrealbuminCD19+ B cellClinical outcomesGastric surgeryGCPrealbumin

Identifiers

PMID40016677
PMCPMC11866875

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.